Encapsulated plant extract (Gelsemium sempervirens) poly (lactide-co-glycolide) nanoparticles enhance cellular uptake and increase bioactivity in vitro

Experimental Biology and Medicine

Volumn 235, Issue 6, 2010, Pages 678-688

  Bhattacharyya, Soumya Sundar ^a   Paul, Saili ^a   Khuda Bukhsh, Anisur Rahman ^a  

^a UNIVERSITY OF KALYANI   (India)

Author keywords

A375 cell line; Apoptosis; Biodegradable polymer; Gelsemium sempervirens; In vitro; Nanoparticle encapsulation; PLGA

Indexed keywords

BETA ACTIN; CASPASE 3; CYCLIN D1; GELSENIUM SEMPERVIRENS EXTRACT; NANOPARTICLE; PLANT EXTRACT; POLYGLACTIN; PROTEIN P53; SURVIVIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG FORMULATION; GELSENIUM SEMPERVIRENS; HUMAN; HUMAN CELL; MEDICINAL PLANT; NANOENCAPSULATION; PARTICLE SIZE; SKIN CANCER; ZETA POTENTIAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; DRUG CARRIERS; GELSEMIUM; HUMANS; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; PLANT EXTRACTS; POLYGLACTIN 910;

GELSEMIUM SEMPERVIRENS; LOGANIACEAE;

EID: 77953206435     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2010.009338     Document Type: Article

References (17)

1. Bundscherer A, Hafner C, Maisch T, Becker B, Landthaler M, Vogt T. Antiproliferative and proapoptotic effects of rapamycin and celecoxib in malignant melanoma cell lines. Oncol Rep 2008;19:547-553 (Pubitemid 351176119)
2. Hafner C, Reichle A, Vogt T. New indications for established drugs: combined tumor-stroma-targeted cancer therapy with PPARgamma agonists, COX 2 inhibitors, mTOR antagonists and metronomic chemotherapy. Curr Cancer Drug Targets 2005;5:393-419
3. Boericke W. Pocket Manual of Homeopathic Materia Medica. Indian Edition. Calcutta, India: Sett Dey and Co., 1976
4. Bhattacharyya SS, Mandal SK, Biswas R, Paul S, Pathak S, Boujaedaini N, Belon P, Khuda-Bukhsh AR. In vitro studies demonstrate anticancer activity of an alkaloid of plant Gelsemium semipervirens. Exp Biol Med 2008;233:1591-1601
5. Fessi H, Puisieux F, Devissaquet JP, Ammoury N, Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm 1989;55:R1-4
6. Mossman T. Rapid colorimetric assay for cellular growth and survival. J Immunol Method 1986;65:55
7. Darzynkiewicz Z, Galkowski D, Zhao H. Analysis of apoptosis by cytometry using TUNEL assay. Methods 2008;44:250-254
8. Dong YC, Feng SS. Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. Biomaterials 2004;25:2843-2849
9. Savic R, Luo L, Eisenberg A, Maysinger D. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 2003;300:615-618
10. Gaucher G, Dufresne MH, Sant VP, Kang N, Maysinger D, Leroux JC. Block copolymer micelles: preparation, characterization and application in drug delivery. J Control Release 2005;109:169-188
11. Evans WC. Pharmacognosy. Edinburgh: Elsevier Science Limited, 2002
12. Takayama H, Sakai S. Gelsemium Alkaloids. Vol. 49. In: The Alkaloids. New York: Academic Press, 1997:1-78
13. Ankola DD, Viswanad B, Bhardwaj V, Ramarao P, Kumar MN. Development of potent oral nanoparticulate formulation of coenzyme Q10 for treatment of hypertension: can the simple nutritional supplements be used as first line therapeutic agents for prophylaxis/therapy? Eur J Pharm Biochem 2007;67:361-369
14. Kim TY, Kim DW, Chung JY, Shin SG, Kim SC, Heo DS, Kim NK, Banq YJ. Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelleformulated paclitaxel, in patients with advanced malignancies. Clin Cancer Res 2004;10:3708-3716
15. Vasey PA, Kaye SB, Morrison R, Twelves C, Wilson P, Duncan R, Thomson AH, Murray LS, Hilditch TE, Murray TE, Burtles S, Fraier D frigerio E, Cassidy J. Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)- methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee. Clin Cancer Res 1999;5:83-94
16. Bisht S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A, Maitra A. Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy. J Nanobiotechnol 2007;5:3
17. Anand P, Nair HS, Sung B, Kunnumakkara AB, Yadav VR, Tekmal RR, Aggarwal BB. Design of curcumin loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem Pharmacol 2010;79:330-338